- Sparta Group (SAY) has signed an MOU with Ethema Health Corporation to explore the use of hypochlorous acid (HOCI) fogging
- Fogging with HOCI has been found to be both a safe and effective means of disinfecting any number of settings including farming, restaurants and health care
- HOCI is EPA registered and FDA approved for wound care and various forms of food processing
- Ethema Health Corporation operates in the behavioral healthcare space specifically in the treatment of substance use disorders
- Sparta Group owns or holds a controlling interest in a network of independent businesses that supply energy-saving technologies
- Sparta Group (SAY) is down 2.44 per cent, trading at C$0.20 per share at 9:40 am EST
Sparta Group (SAY) has signed a Memorandum of Understanding (“MOU”) with Ethema Health Corporation.
This MOU could provide Sparta with the opportunity to expand into new markets related to the fight against emerging pathogens, including SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
For over 40 years, the food processing industry has been expanding technology to include various forms of pathogen-killing processing equipment.
Much of the continuous pathogen protection revolves around the use of a naturally occurring substance known as hypochlorous acid (“HOCl”). Both beef and poultry processors have discovered that hypochlorous acid is effective, affordable, and safe to use.
With a number of COVID-19 variants circulating the globe and some experts talking about a third wave to the pandemic, the two joint venture partners have decided to explore the use of HOCl disinfectant technologies in various market verticals, including health-related and industrial manufacturing settings.
Hypochlorous acid has been used in many different industries. A recent U.S. National Library of Medicine paper indicates that HOCI has multiple uses, including in farming, restaurants, and health care.
Ethema Health develops specialized world-class health centers for addiction treatment.
Hypochlorous acid is naturally produced by our white blood cells and is an important part of the human immune system. HOCl mimics the human immune system’s neutrophils; releasing their attack to destroy pathogenic organisms.
While safe for humans, HOCI can be a powerful weapon against viral outbreaks.
HOCI is EPA registered and FDA approved for wound care and various forms of food processing.
“We already have the programs in place to provide long-term antimicrobial protection for virtually all workplace surfaces; the ability to provide app-based ACHU@work technology to monitor the health of the individual workers via a wearable (such as a Fitbit® or Apple Watch®); and we have COVID-19 rapid testing capability to help employers maintain a safe workforce. So, adding continuous pathogen protection that can be provided through the application of HOCl technology makes a lot of sense. We are so pleased to have our scientific teams collaborating to see how we can open up more opportunities to distribute this clean, green and safe solution,” said, Sparta President John O’Bireck.
“Thanks to advances in technology made in the food processing arena it is our expectation that we will be able to offer an affordable and residue-free hypochlorous acid solution that can be used in various markets,” said Mr. Len Shara P.Eng., Sparta Group’s Lead Scientist and member of Sparta’s Technical Advisory Board.
Ethema Health Corporation (GRST) operates in the behavioural healthcare space specifically in the treatment of substance use disorders.
Sparta Group is a technology-based company that owns or holds a controlling interest in a network of independent businesses that supply energy-saving technologies designed to reduce energy inefficiencies, achieve reduced emissions and increase operating efficiencies in various industries.
Sparta Group (SAY) is down 2.44 per cent, trading at C$0.20 per share at 9:40 am EST.
